Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies ...

A federal judge on Friday said 36 drugmakers and executives must face nearly all claims in an antitrust lawsuit brought by ...

During the Medicare annual enrollment period (AEP) for 2026 plans, you can expect changes in premiums and out-of-pocket costs ...

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.

Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.

In Massachusetts, the federal government spends $1.5 billion annually to subsidize health coverage for residents. At the end ...

Oil prices rose $0.82 a barrel Friday morning following reports that the U.S. may strike military targets within Venezuela that the Trump administration associates with drug trafficking. Prices then ...

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Lyndell “Lynn" Price, the former co-owner of Houston's Turkey Leg Hut, is now facing additional federal gun-related charges.

Evommune is set to make its stock market debut next week, but the biotech company is keeping investors guessing about its final share price.